JAZZ - Jazz Pharmaceuticals plc
IEX Last Trade
115.9
0.300 0.259%
Share volume: 365,740
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$115.60
0.30
0.26%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-09 | 2023-03-01 | 2023-05-10 | 2023-08-09 | 2023-11-08 | 2024-02-28 | 2024-05-02 | 2024-08-01 | |
| Assets | |||||||||
| Total Assets | 10.385 B | 10.835 B | 11.047 B | 11.261 B | 11.204 B | 11.393 B | 11.327 B | 11.362 B | |
| Current Assets | 2.572 B | 2.606 B | 2.785 B | 3.010 B | 3.246 B | 3.435 B | 3.540 B | 3.682 B | |
| Inventories | 728.074 M | 714.061 M | 674.778 M | 657.214 M | 611.827 M | 597.039 M | 577.321 M | 542.555 M | |
| Other Current Assets | 342.893 M | 359.104 M | 318.023 M | 379.948 M | 420.394 M | 506.285 M | 437.097 M | 460.272 M | |
| Short Term Investments | 342.893 M | 359.104 M | 318.023 M | 379.948 M | 420.394 M | 506.285 M | 437.097 M | 460.272 M | |
| Total Receivables | 601.179 M | 651.493 M | 623.938 M | 610.389 M | 627.841 M | 705.794 M | 707.095 M | 698.037 M | |
| Current Cash | 899.358 M | 881.482 M | 1.168 B | 1.362 B | 1.586 B | 1.626 B | 1.818 B | 1.981 B | |
| Total Non-current Assets | 7.813 B | 8.229 B | 8.262 B | 8.251 B | 7.958 B | 7.958 B | 7.787 B | 7.680 B | |
| Property Plant Equipment | 216.339 M | 228.050 M | 227.552 M | 229.264 M | 222.476 M | 169.646 M | 166.236 M | 169.281 M | |
| Other Assets | 45.102 M | 64.393 M | 72.635 M | 73.843 M | 83.252 M | 73.942 M | 76.564 M | 77.161 M | |
| Intangible Assets | 5.570 B | 5.794 B | 5.764 B | 5.706 B | 5.418 B | 5.418 B | 5.235 B | 5.079 B | |
| Goodwill | 1.593 B | 1.693 B | 1.723 B | 1.743 B | 1.705 B | 1.753 B | 1.739 B | 1.736 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 10.385 B | 10.835 B | 11.047 B | 11.261 B | 11.204 B | 11.393 B | 11.327 B | 11.362 B | |
| Total liabilities | 7.639 B | 7.750 B | 7.712 B | 7.735 B | 7.715 B | 7.656 B | 7.631 B | 7.599 B | |
| Total current liabilities | 812.954 M | 933.193 M | 908.902 M | 945.265 M | 1.573 B | 1.537 B | 1.562 B | 1.556 B | |
| Accounts Payable | 102.249 M | 90.758 M | 125.454 M | 98.428 M | 109.850 M | 102.750 M | 80.976 M | 97.096 M | |
| Other liabilities | 124.051 M | 106.812 M | 109.178 M | 126.683 M | 127.480 M | 104.751 M | 97.425 M | 99.416 M | |
| Current long term debt | 31.000 M | 31.000 M | 31.000 M | 31.000 M | 604.507 M | 604.954 M | 605.375 M | 605.798 M | |
| Long term debt | 5.696 B | 5.693 B | 5.690 B | 5.687 B | 5.111 B | 5.108 B | 5.105 B | 5.101 B | |
| Other liabilities | 124.051 M | 106.812 M | 109.178 M | 126.683 M | 127.480 M | 104.751 M | 97.425 M | 99.416 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 2.745 B | 3.086 B | 3.335 B | 3.526 B | 3.489 B | 3.737 B | 3.696 B | 3.763 B | |
| Common stock | 62.785 M | 63.070 M | 63.494 M | 63.991 M | 63.114 M | 62.565 M | 62.537 M | 62.882 M | |
| Retained earnings | 974.310 M | 733.586 M | 803.006 M | 811.849 M | 884.298 M | 878.656 M | 864.038 M | 871.178 M |